Nystatin-Neomycin Sulfate-Thiostrepton-Triamcinolone Acetonide Ointment
43 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
43
Total Reports
6
Deaths Reported
1400.0%
Death Rate
Active Ingredients
Nystatin-Neomycin Sulfate-Thiostrepton-Triamcinolone Acetonide Ointment
Administration Routes
UnknownAuricular (Otic)Topical
Species Affected
Dog 35
Cat 8
Most Affected Breeds
Domestic Shorthair 6
Retriever - Labrador 6
Shiba Inu 4
Spaniel - Cocker American 2
Bulldog - French 2
Dog (other) 2
Dog (unknown) 2
Terrier - Irish Soft-coated Wheaten 1
Retriever - Golden 1
Lhasa Apso 1
Most Reported Reactions
Vomiting 12
Lethargy (see also Central nervous system depression in 'Neurological') 10
Lack of efficacy - NOS 4
Other abnormal test result NOS 4
Seizure NOS 4
Ear discharge 4
Decreased appetite 4
Dehydration 3
Death by euthanasia 3
Behavioural disorder NOS 3
Other ear disorder NOS 3
Depression 3
Outcome Breakdown
Ongoing
17 (39.5%)
Outcome Unknown
12 (27.9%)
Recovered/Normal
8 (18.6%)
Died
3 (7.0%)
Euthanized
3 (7.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.